Long Wharf Investors’s AstraZeneca AZN Stock Holding History

Long Wharf Investors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$567K	Buy	7,633 +280	+4%	+$20.2K	0.45%	78
2014 Q1	$477K	Sell	7,353 -1,286	-15%	-$83.1K	0.41%	91
2013 Q4	$513K	Buy	8,639 +140	+2%	+$7.61K	0.46%	72
2013 Q3	$441K	Sell	8,499 -821	-9%	-$41.2K	0.42%	81
2013 Q2	$441K	Buy	+9,320	New	+$475K	0.43%	77

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Long Wharf Investors's AZN Position: Q2 2014 in Review

Long Wharf Investors increased its AstraZeneca (AZN) stake by 3.8% in Q2 2014, buying an estimated $20.2K and bringing the position to 7,633 shares worth $567K. The position accounts for 0.45% of the portfolio, ranked #78.

Long Wharf Investors first reported a position in AZN in Q2 2013 and has held it in 5 quarters since. 418 funds tracked by Wall St. Rank hold AZN as of Q2 2014.

Long Wharf Investors held 7,633 shares of AstraZeneca worth $567K as of Q2 2014.
Long Wharf Investors bought 280 AstraZeneca shares in Q2 2014, an estimated $20.2K.
AstraZeneca made up 0.45% of Long Wharf Investors's portfolio in Q2 2014, its #78 holding.
Long Wharf Investors first reported a position in AstraZeneca in Q2 2013 and has held it in 5 quarters since.
418 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2014.

Based on Long Wharf Investors's 13F filing for Q2 2014, filed 4 Aug 2014.